CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably and with almost zero adverse effects. Founded in 2017 by ophthalmic surgeon and inventor Philippe Sourdille, and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept CID is the first implant in the industry to reduce IntraOcular Pressure (IOP) without penetrating the anterior chamber or creating subconjunctival filtration. The implant is applicable as a standalone procedure for glaucoma, an aging disease that, globally, affects 80M people per year; or it can be combined with cataract removal. The company is located near Annecy, France. www.cilia.tech
Location: France, Auvergne-Rhone-Alpes, Chavanod
Employees: 1-10
Total raised: $3.86M
Founded date: 2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.04.2023 | - | $3.86M | Kreaxi |
Mentions in press and media 2
| Date | Title | Description |
| 25.04.2023 | Ciliatech Raises €3.5M in Funding | Ciliatech, a Chavanod, France-based ophthalmology medtech company, raised €3.5M in funding. This Series A funding is composed of: €1.75M in capital, and €1.75M in bank loans. Founded in 2017 by CEO Olivier Benoit and Philippe Sourdille, Cil... |
| - | Ciliatech | “Discover CID (Cilio-Scleral Inter-positioning Device), the first implant to effectively reduce IntraOcular Pressure (IOP) without penetrating the anterior chamber or creating subconjunctival filtration – critical measures that overcome the... |